ScienceVirtual Biotech aims to inform drug-development decisions with multi-agent AI
Science says the system combines biomedical and clinical evidence in one platform and may help identify therapeutic opportunities that would otherwise be missed.
TLDR
Science reports that researchers have presented Virtual Biotech, a multi-agent AI system designed to inform drug-development decisions. It combines diverse biomedical and clinical evidence in a unified platform. The magazine says the system may help identify therapeutic opportunities that would otherwise be missed.
Virtual Biotech aims to inform drug-development decisions with multi-agent AI
Science says the system combines biomedical and clinical evidence in one platform and may help identify therapeutic opportunities that would otherwise be missed.
TLDR
Science reports that researchers have presented Virtual Biotech, a multi-agent AI system designed to inform drug-development decisions. It combines diverse biomedical and clinical evidence in a unified platform. The magazine says the system may help identify therapeutic opportunities that would otherwise be missed.
